Adverse Reactions of COVID-19 Vaccines: A Scoping Review of Observational Studies

References

• Wang J, Kaperak C, Sato T, Sakuraba A. COVID-19 reinfection: a rapid systematic review of case reports and case series. J Invest Med. 2021;69(6):1253–1255. doi:10.1136/jim-2021-001853
   PubMed Web of Science ®Google Scholar
• Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol. 2021;105:441–455. doi:10.1007/s00253-020-11061-5/Published
   PubMed Web of Science ®Google Scholar
• IHME. COVID-19 results briefing Myanmar current situation trends in drivers of transmission. COVID-19 Results Brief; 2022. Available from: https://www.healthdata.org/sites/default/files/covid_briefs/15_briefing_Myanmar.pdf. Accessed October 27, 2022.
   Google Scholar
• rawson T, Brewer T, Veltcheva D, Huntingford C, Bonsall MB. How and when to end the COVID-19 lockdown: an optimization approach. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00262
   Web of Science ®Google Scholar
• Shen M, Xiao Y, Zhuang G, Li Y, Zhang L. Mass testing—An underexplored strategy for COVID-19 control. Innovation. 2021;2(2):100114. doi:10.1016/j.xinn.2021.100114
   Google Scholar
• Warren GW, Lofstedt R. COVID-19 vaccine rollout risk communication strategies in Europe: a rapid response. J Risk Res. 2021;24(3–4):369–379. doi:10.1080/13669877.2020.1870533
   Web of Science ®Google Scholar
• Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical outcomes of a COVID-19 vaccine: implementation over efficacy. Health Aff. 2021;40(1):42–52. doi:10.1377/hlthaff.2020.02054
   Web of Science ®Google Scholar
• Al Khames Aga QA, Alkhaffaf WH, Hatem TH. Safety of COVID-19 vaccines. J Med Virol. 2021;93(12):6588–6594. doi:10.1002/jmv.27214
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/nejmoa2035389
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/nejmoa2034577
   PubMed Web of Science ®Google Scholar
• Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384(23):2187–2201. doi:10.1056/nejmoa2101544
   PubMed Web of Science ®Google Scholar
• Beatty AL, Peyser ND, Butcher XE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12):e2140364. doi:10.1001/jamanetworkopen.2021.40364
   PubMed Web of Science ®Google Scholar
• Spencer JP, Trondsen Pawlowski RH, Thomas S. Vaccine adverse events: separating myth from reality. Am Fam Physician. 2017;95(12):786–794.
   PubMed Web of Science ®Google Scholar
• Abu-Halaweh S, Alqassieh R, Suleiman A, et al. Qualitative assessment of early adverse effects of pfizer–biontech and sinopharm covid-19 vaccines by telephone interviews. Vaccines. 2021;9(9):950. doi:10.3390/vaccines9090950
   Web of Science ®Google Scholar
• Rabail R, Ahmed W, Ilyas M, et al. The side effects and adverse clinical cases reported after COVID-19 Immunization. Vaccines. 2022;10(4):1–25. doi:10.3390/vaccines10040488
   Web of Science ®Google Scholar
• Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia. BMC Public Health. 2021;21(1). doi:10.1186/s12889-021-11501-5
   PubMed Web of Science ®Google Scholar
• Kreps S, Prasad S, Brownstein JS, et al. Factors associated with US Adults’ likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.25594
   PubMed Web of Science ®Google Scholar
• Cerda AA, García LY. Hesitation and refusal factors in individuals’ decision-making processes regarding a coronavirus disease 2019 vaccination. Front Public Health. 2021;9. doi:10.3389/fpubh.2021.626852
   PubMed Web of Science ®Google Scholar
• Peters M, Godfrey C, McInerner P, Munn Z, Tricco A, Khalil H. Chapter 11: scoping reviews (2020 version). JBI Man Evid Synth. 2020. doi:10.46658/JBIMES-20-12
   Google Scholar
• Pormohammad A, Zarei M, Ghorbani S, et al. Efficacy and safety of covid-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines. 2021;9(5):467. doi:10.3390/vaccines9050467
   PubMed Web of Science ®Google Scholar
• Chen J, Cai Y, Chen Y, Williams AP, Gao Y, Zeng J. Nervous and muscular adverse events after covid‐19 vaccination: a systematic review and meta‐analysis of clinical trials. Vaccines. 2021;9(8):939. doi:10.3390/vaccines9080939
   PubMed Web of Science ®Google Scholar
• Bosdriesz JR, Stel VS, van Diepen M, et al. Evidence-based medicine—When observational studies are better than randomized controlled trials. Nephrology. 2020;25(10):737–743. doi:10.1111/nep.13742
   PubMed Web of Science ®Google Scholar
• Kamioka H. Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015 statement. Japanese Pharmacol Ther. 2019;47(8):1177–1185.
   Google Scholar
• Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949. doi:10.1016/S1473-3099(21)00224-3
   PubMed Web of Science ®Google Scholar
• Perrotta A, Biondi-Zoccai G, Saade W, et al. A snapshot global survey on side effects of cOvid-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Med. 2021;63(3):324–331. doi:10.23736/S0031-0808.21.04435-9
   PubMed Web of Science ®Google Scholar
• Ganesan S, Al Ketbi LMB, Al Kaabi N, et al. Vaccine side effects following COVID-19 vaccination among the residents of the UAE—an observational study. Front Public Health. 2022;10. doi:10.3389/fpubh.2022.876336
   PubMed Web of Science ®Google Scholar
• Rosenblum HG, Gee J, Liu R, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the vaccine adverse event reporting system and v-safe. Lancet Infect Dis. 2022;22(6):802–812. doi:10.1016/S1473-3099(22)00054-8
   PubMed Web of Science ®Google Scholar
• Lee SW, Moon JY, Lee SK, et al. Anti-SARS-CoV-2 Spike Protein RBD antibody levels after receiving a second dose of ChAdOx1 nCov-19 (AZD1222) vaccine in healthcare workers: lack of association with age, sex, obesity, and adverse reactions. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.779212
   Web of Science ®Google Scholar
• Bsoul EA, Loomer PM, Patel SKS. COVID-19 vaccination experience among United States dental professionals and students: safety, confidence, concerns, and side effects. PLoS One. 2022;17(2):e0264323. doi:10.1371/journal.pone.0264323
   PubMed Web of Science ®Google Scholar
• Zavala-Flores E, Salcedo-Matienzo J, Quiroz-Alva A, Berrocal-Kasay A. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus. Clin Rheumatol. 2022;41(5):1349–1357. doi:10.1007/s10067-021-05980-5
   PubMed Web of Science ®Google Scholar
• Shulman RM, Weinberg DS, Ross EA, et al. Adverse events reported by patients with cancer after administration of a 2-dose mRNA COVID-19 vaccine. J Natl Comprehen Cancer Netw. 2022;20(2):160–166. doi:10.6004/jnccn.2021.7113
   PubMed Web of Science ®Google Scholar
• Jeong S, Hong S, Oh T, et al. Analysis of older adults visiting the emergency department with fever as a suspected Covid-19 vaccine-related adverse reaction: a retrospective multicenter study. J Infect Chemother. 2022;28(8):1159–1164. doi:10.1016/j.jiac.2022.04.022
   PubMed Web of Science ®Google Scholar
• Oh TH, Woo SH, Hong S, Lee C, Lee WJ, Jeong SK. Clinical features of patients presenting to the emergency department with cardiovascular adverse reactions after COVID-19 mRNA vaccination. J Korean Med Sci. 2022;37(9). doi:10.3346/jkms.2022.37.e73
   Web of Science ®Google Scholar
• Park C, Sakong J, Jo S, Kim M, Baek K. Adverse effects on work and daily life interference among healthcare workers after the first and second chadox1 and bnt162b2 covid-19 vaccine doses. Vaccines. 2021;9(8):926. doi:10.3390/vaccines9080926
   Web of Science ®Google Scholar
• Thomas SJ, Moreira ED, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021;385(19):1761–1773. doi:10.1056/nejmoa2110345
   PubMed Web of Science ®Google Scholar
• Lee YW, Lim SY, Lee JH, et al. Adverse reactions of the second dose of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in Korea. J Korean Med Sci. 2021;36(21):1–6. doi:10.3346/JKMS.2021.36.E153
   Web of Science ®Google Scholar
• Kim SH, Wi YM, Yun SY, et al. Adverse events in healthcare workers after the first dose of Chadox1 Ncov-19 Or Bnt162b2 mRNA Covid-19 vaccination: a single center experience. J Korean Med Sci. 2021;36(14):1–8. doi:10.3346/jkms.2021.36.e107
   Web of Science ®Google Scholar
• Klimek L, Bergmann KC, Brehler R, et al. Practical handling of allergic reactions to COVID-19 vaccines: a position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI. Allergo J Int. 2021;30(3):79–95. doi:10.1007/s40629-021-00165-7
   PubMedGoogle Scholar
• Kaur RJ, Dutta S, Charan J, et al. Cardiovascular adverse events reported from covid-19 vaccines: a study based on who database. Int J Gen Med. 2021;14:3909–3927. doi:10.2147/IJGM.S324349
   PubMedGoogle Scholar
• Banerji A, Wickner PG, Saff R, et al. mRNA Vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol. 2021;9(4):1423–1437. doi:10.1016/j.jaip.2020.12.047
   Web of Science ®Google Scholar
• Kadali RAK, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis. 2021;106:376–381. doi:10.1016/j.ijid.2021.04.047
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye Q. Safety and Efficacy of the Common Vaccines against COVID-19. Vaccines. 2022;10(4):513. doi:10.3390/vaccines10040513
   Web of Science ®Google Scholar
• Liu JY, Chen TJ, Hou MC. Does COVID-19 vaccination cause excess deaths? J Chin Med Assoc. 2021;84(9):811–812. doi:10.1097/JCMA.0000000000000580
   PubMed Web of Science ®Google Scholar